"Successful automation depends on orchestration, not just robotics," notes Werner Maas, PhD, CEO, Hudson Lab Automation.
UC labs are developing new treatments that don’t just prevent damage from getting worse, but — for the first time in medical ...
Total Revenues of $599 million for the Fourth Quarter of 2025, $2.320 billion for the Fiscal Year 2025 –– Cabozantinib Franchise Achieved $2.123 billion in U.S. Net Product Revenues for the Fiscal ...
The PROTAC market is experiencing rapid growth, driven by rising interest in targeted protein degradation as a next-generation therapeutic approach. Expanding oncology pipelines with drugs in clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results